AbCellera Biologics - Stock Price History | ABCL

Historical daily share price chart and data for AbCellera Biologics since 2021 adjusted for splits. The latest closing stock price for AbCellera Biologics as of September 27, 2021 is 20.99.
  • The all-time high AbCellera Biologics stock closing price was 58.90 on December 11, 2020.
  • The AbCellera Biologics 52-week high stock price is 71.91, which is 242.6% above the current share price.
  • The AbCellera Biologics 52-week low stock price is 14.51, which is 30.9% below the current share price.
  • The average AbCellera Biologics stock price for the last 52 weeks is 29.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AbCellera Biologics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 45.7314 58.9000 58.9000 39.0000 40.2400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.850B $0.233B
AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29